Bryn Mawr Trust Advisors LLC Makes New $2.35 Million Investment in Waters Corporation $WAT

Bryn Mawr Trust Advisors LLC acquired a new stake in Waters Corporation (NYSE:WAT) during the 2nd quarter, Holdings Channel reports. The firm acquired 6,268 shares of the medical instruments supplier’s stock, valued at approximately $2,351,000.

A number of other hedge funds have also recently made changes to their positions in the business. California Public Employees Retirement System lifted its stake in Waters by 25.4% in the 1st quarter. California Public Employees Retirement System now owns 138,423 shares of the medical instruments supplier’s stock worth $41,222,000 after purchasing an additional 28,074 shares in the last quarter. Banque Cantonale Vaudoise grew its position in shares of Waters by 329.0% during the fourth quarter. Banque Cantonale Vaudoise now owns 4,294 shares of the medical instruments supplier’s stock valued at $1,631,000 after purchasing an additional 3,293 shares in the last quarter. Ramsay Stattman Vela & Price Inc. bought a new stake in shares of Waters in the first quarter worth about $942,000. Rockefeller Capital Management L.P. increased its holdings in shares of Waters by 106.7% in the fourth quarter. Rockefeller Capital Management L.P. now owns 2,751 shares of the medical instruments supplier’s stock worth $1,045,000 after purchasing an additional 1,420 shares during the last quarter. Finally, Dudley & Shanley Inc. lifted its position in shares of Waters by 101.3% in the second quarter. Dudley & Shanley Inc. now owns 23,590 shares of the medical instruments supplier’s stock worth $8,847,000 after buying an additional 11,870 shares in the last quarter. Institutional investors own 94.01% of the company’s stock.

Waters Stock Down 0.4%

Shares of NYSE:WAT opened at $411.88 on Friday. The company has a market cap of $40.47 billion, a price-to-earnings ratio of 102.71, a PEG ratio of 2.40 and a beta of 1.19. Waters Corporation has a 12 month low of $282.77 and a 12 month high of $420.26. The company has a current ratio of 1.86, a quick ratio of 0.50 and a debt-to-equity ratio of 0.32. The company has a 50-day moving average price of $377.18 and a 200 day moving average price of $346.31.

Waters (NYSE:WAT) last issued its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $3.05 earnings per share for the quarter, topping the consensus estimate of $3.01 by $0.04. Waters had a return on equity of 11.27% and a net margin of 3.58%.The company had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.62 billion. During the same period in the previous year, the firm posted $2.95 earnings per share. The firm’s revenue for the quarter was up 113.3% on a year-over-year basis. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. As a group, equities research analysts predict that Waters Corporation will post 14.57 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on WAT shares. Wells Fargo & Company increased their price target on Waters from $370.00 to $400.00 and gave the company an “equal weight” rating in a research note on Wednesday, August 5th. Wolfe Research initiated coverage on Waters in a research note on Tuesday, June 2nd. They issued an “outperform” rating and a $425.00 price objective on the stock. Royal Bank Of Canada upped their price objective on Waters from $435.00 to $475.00 and gave the stock an “outperform” rating in a report on Wednesday, August 5th. The Goldman Sachs Group increased their target price on Waters from $380.00 to $425.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Finally, Guggenheim reissued a “buy” rating and issued a $440.00 target price on shares of Waters in a report on Wednesday, July 8th. Three equities research analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $420.35.

Insider Activity at Waters

In other news, Director Christopher A. Kuebler sold 3,626 shares of the business’s stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the transaction, the director owned 17,808 shares of the company’s stock, valued at approximately $7,086,515.52. The trade was a 16.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 0.31% of the company’s stock.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.